Summary of the Conference Call for Yisheng Co., Ltd. Industry Overview - The poultry industry is currently facing challenges due to high pathogenic avian influenza, particularly affecting the importation of grandparent breeding chickens from France, which has been suspended since late January 2026. [2][4] - The impact of avian influenza has led to a reduction in the import volume of grandparent chickens by 10%, which may influence market supply and pricing dynamics for chicken and meat products. [3][19] Key Points and Arguments - **Supply and Pricing Dynamics**: - The price of parent breeding chickens has increased since September 2025, currently around 50 yuan, due to a significant import volume in 2025. [2][4] - In Q4 2025, Yisheng sold over 3.5 million sets of parent breeding chickens at an average price of over 33 yuan, and 162 million commercial chicks at an average price of 3.4 yuan. [9] - The price of commercial broilers reached a peak of 3.85 yuan per jin in December 2025, supported by rising meat prices and reduced supply. [11] - **Impact of Diseases**: - Seasonal diseases, particularly tumors and stress-related issues, are expected to affect breeding efficiency in 2026, especially in Shandong province, a major breeding area. [12] - **Future Outlook**: - The company anticipates focusing on parent breeding in the first half of 2026 and on commercial breeding in the second half, with expectations of improved market conditions compared to 2024. [13] - The recovery of pork prices is expected to drive up chicken and broiler prices in the latter half of 2026. [13] Additional Important Information - **Capital Expenditure Plans**: - Yisheng plans to increase parent breeding output from 7 million to 10 million sets and expand commercial chick exports from 600 million to 1 billion. The company also plans to invest approximately 500 million yuan in a residential project in Shanxi. [5][15] - **Challenges in Importing**: - The approval process for importing from other regions has become more stringent, with timelines extending to two to three months. Currently, there are no confirmed alternative sources for rapid imports. [6][7] - **Dividend Expectations**: - The company aims to provide returns to shareholders through dividends when conditions allow, though specific timing and amounts remain uncertain due to compliance issues. [16] - **New Product Development**: - Yisheng is actively developing its own egg-laying chicken breeds, with plans to promote a new American breed expected to receive certification in the first half of 2026. [18] - **Market Position**: - Yisheng was previously the largest grandparent breeding chicken company in China, with a strong market share. The introduction of new domestic breeds is expected to enhance competitiveness. [18][21] - **Investment Recommendations**: - Given the current valuation and growth potential, investors are encouraged to pay attention to the white chicken sector, particularly Yisheng, due to its profit elasticity and favorable market conditions. [20]

Core Viewpoint - Yisheng Co., Ltd. has shown a positive stock performance with a 6.68% increase year-to-date and a 2.64% rise on January 8, 2025, indicating potential investor interest in the company [1]. Group 1: Company Overview - Yisheng Co., Ltd. is located in Yantai, Shandong Province, and was established on April 22, 1997, with its stock listed on August 10, 2010 [1]. - The company's main business includes breeding and sales of various generations of meat chickens, pig farming, agricultural equipment production, feed production, dairy farming, and organic fertilizer production [1]. - The revenue composition is as follows: chicken income accounts for 76.18%, pig income for 15.47%, livestock equipment for 5.48%, dairy products for 1.72%, and other income for 1.14% [1]. Group 2: Financial Performance - For the period from January to September 2025, Yisheng Co., Ltd. reported a revenue of 2.036 billion yuan, a year-on-year decrease of 5.44%, and a net profit attributable to shareholders of 31.7869 million yuan, down 89.42% year-on-year [2]. - The company has distributed a total of 1.692 billion yuan in dividends since its A-share listing, with 602 million yuan distributed over the last three years [3]. Group 3: Shareholder and Market Activity - As of September 30, 2025, the number of shareholders for Yisheng Co., Ltd. was 42,200, a decrease of 12.13% from the previous period, while the average circulating shares per person increased by 13.80% to 17,754 shares [2]. - The top ten circulating shareholders include the Guotai Zhongzheng Livestock Breeding ETF, which holds 14.8357 million shares, an increase of 5.3849 million shares from the previous period, and Hong Kong Central Clearing Limited, which is a new shareholder holding 7.1349 million shares [3].

Industry Updates - The National Drug Administration held a meeting emphasizing key tasks for 2026, including ensuring high-level drug safety, supporting the pharmaceutical industry's quality improvement, enhancing legal standards in drug regulation, and advancing modernization in drug supervision [4] - The State Administration for Market Regulation and the National Internet Information Office jointly released regulations to prevent unreasonable restrictions on platform operators and protect consumer rights in online transactions [4] - The Ministry of Industry and Information Technology announced the implementation of "Artificial Intelligence + Manufacturing" initiatives, focusing on accelerating the application of humanoid robots and enhancing the industrialization of AI terminals [7] Company News - Bestme's subsidiary, Yong'an Chemical, is facing criminal charges for environmental pollution due to interference with automatic monitoring facilities [13] - Heng Rui Medicine's subsidiary received approval for a new innovative drug, which is the first of its kind to be approved for treating specific types of cancer [14] - Guangqi Technology signed contracts worth 2.15 billion yuan for the mass production of metamaterials, indicating strong demand in the market [14] - Zhongke Blue Communication expects a significant profit increase of 366.51% to 376.51% in 2025, driven by investments in other companies [15] - Chuanjinno anticipates a net profit of 430 million to 480 million yuan in 2025, reflecting a growth of 144.24% to 172.64% [16] Market Trends - Analysts predict a substantial increase in Samsung Electronics' Q4 2025 earnings, with a projected 160% year-on-year profit surge due to a severe chip shortage driving up storage chip prices [10] - The postal industry plans to introduce policies to promote the application of unmanned delivery technologies, which could lead to significant growth in logistics efficiency [11] - Institutions are increasingly focusing on the semiconductor sector, with a notable recovery in the storage segment, indicating a healthier supply-demand structure [18][19]

每经头条（nbdtoutiao）——十年首现，沪指连续站稳关键位置！高盛：建议高配中国股票！券商分析 师：人民币升值等因素加速跨境资本回流 （记者 张明双） 每经AI快讯，益生股份发布公告称，2026年1月7日，益生股份接受天风证券等投资者调研，公司总 裁、董事会秘书兼财务总监林杰参与接待，并回答了投资者提出的问题。 ...

Group 1: Company Overview - Yisheng Co., established in 1989, is the largest ancestor meat chicken breeding enterprise in China and Asia, holding approximately one-third of the domestic imported breeding chicken market [1][2] - The company has implemented a source purification strategy to ensure the health of breeding chickens, achieving high market recognition for product quality [2] Group 2: Production and Sales Performance - In 2025, the company sold over 640 million commercial white feather broiler chicks, a 20-fold increase compared to over 30 million before going public [2] - The company plans to sell nearly 30,000 breeding pigs in 2024 and 98,000 in 2025, with production capacity steadily increasing [2] Group 3: Market Conditions and Pricing - The price of parent breeding chickens has been rising since September 2025, with current prices exceeding 53 yuan per set [3][10] - The company sold over 1.63 billion commercial white feather broiler chicks in Q4 2025, with prices at their highest for the year [8] Group 4: Impact of Avian Influenza - The introduction of breeding chickens from France was affected by avian influenza outbreaks, leading to a suspension of planned imports [4] - In 2025, the company imported 266,000 sets of breeding chickens, accounting for over 40% of the national total [4] Group 5: Future Outlook - The company anticipates a continued increase in the price of parent breeding chickens due to tight supply from ancestor imports, with expectations for a favorable market in 2026 [10] - Plans to expand production capacity include increasing parent breeding stock to 10 million sets and commercial chick production to 1 billion over the next four years [10] Group 6: Strategic Changes - The company is considering changes in fundraising usage due to regulatory policies and aims to expand through acquisitions and international market exploration [10]

Summary of Key Points from the Conference Call Industry Overview - The conference call discusses the livestock industry, specifically focusing on the pig, chicken, and beef markets in China for the years 2025 and 2026 [1][3][14]. Core Insights and Arguments Pig Farming Sector - The pig farming sector is expected to experience significant impacts from the 2025 production capacity policies, leading to a slowdown in profit growth for leading companies and a downward adjustment of 2026 output targets [1][2]. - In 2025, the average price of pigs peaked at 16 RMB/kg but fell to 11 RMB/kg by the fourth quarter, indicating a trend of increasing supply due to rising breeding sow inventory [2]. - For 2026, it is anticipated that pig prices will continue to decline in the first half, with a focus on cost control and cash flow management being critical for companies [3]. Chicken Industry - The white chicken sector has faced two years of downturn, but the exit of small and medium enterprises is expected to stabilize the industry, leading to improved profitability and dividends ahead of the pig market [1][6]. - Leading companies in the white chicken sector, such as Shengnong, Hefeng, and Yisheng, have maintained profitability during price declines, with improved gross margins expected to yield significant profit elasticity when prices recover [10]. - The yellow chicken market, despite expansion by companies like Lihua and Wens, is projected to perform better in 2026, with price recovery anticipated in the second half of 2025 [12]. Beef Market - The beef market is showing signs of recovery since late 2025, with expectations of increased prices in 2026 due to reduced supply from exiting smallholders [3][13]. - The lack of publicly listed companies focused on beef cattle farming in China presents investment opportunities primarily in Hong Kong-listed dairy companies [3][13]. Investment Strategies - Investors are advised to focus on two types of companies in 2026: those with significant cost improvements, such as Muyuan Foods, and growth-oriented companies like Tiankang Biological, which are pursuing growth through acquisitions [1][5]. - Attention should also be given to fluctuations in agricultural product prices and production metrics such as survival rates and PSY (Production per Sow per Year) [5]. Additional Important Insights - The white chicken industry is currently facing challenges, with prices at historical lows, but the ongoing exit of smaller players is expected to lay the groundwork for future recovery [7][9]. - The overall outlook for the livestock sector in 2026 is more optimistic than in 2025, with potential for price recovery in white chicken and market expansion in yellow chicken [14][15]. This summary encapsulates the key points discussed in the conference call, providing a comprehensive overview of the livestock industry's current state and future outlook.

Market Strategy - The market continues to rise with increased volume, and the Shanghai Composite Index has broken through previous highs [5][10] - The overall A-share market saw a rise of 1.59%, with the Shanghai Composite Index up by 1.50% and the ChiNext Index up by 0.75% [7] - The performance of the hard technology sector is leading, while the innovation growth sector is lagging [8] Industry Dynamics - Global sodium-ion battery shipments are expected to reach 9 GWh in 2025, a year-on-year increase of 150% [26] - The main applications for sodium-ion batteries include energy storage, light electric vehicles, and AI data centers, with significant market share growth [27] - NVIDIA has launched the Rubin platform, designed for AI supercomputing, featuring six new chips that enhance training speed and reduce costs [28][29] Company Updates - Haizhi Science (002653.SZ) has received acceptance for its innovative drug HSK39297 for treating paroxysmal nocturnal hemoglobinuria [32] - Meiya Optoelectronics (002690) won a lawsuit with compensation exceeding 198 million yuan [34] - Yisheng (002458.SZ) reported a 40% year-on-year increase in white feather chick sales in December 2025, while breeding pig sales declined by 43% [36] - Shennong Group (605296.SH) sold 3.0742 million pigs in 2025, generating revenue of 4.729 billion yuan [38] - Taotao Vehicle (301345.SZ) expects a net profit of 800-850 million yuan for 2025, a year-on-year increase of 85.5%-97.1% [41] - Ugreen Technology (301606.SZ) anticipates a net profit of 653-733 million yuan for 2025, reflecting a growth of 41.26%-58.56% [43]

Investment Rating - The report assigns a target price of RMB 11.30 for the company based on a 2026 PE of 20X, reflecting its leading position and expected profit improvement trend [5][9]. Core Insights - The white chicken industry is expected to gradually recover in price, with the company focusing on the most profitable breeding segment, indicating a potential for continued sales growth and improved profitability per bird [2][5]. - The company is the largest grandparent meat breeder in China, holding approximately one-third of the domestic market, and has shown significant sales growth in parent breeders and chicks [5][18]. - The hog business is also expanding, with a gross profit margin of 25.5% in the first half of 2025, indicating a strong performance compared to peers [5][18]. - Profitability is anticipated to increase in 2026 as industry capacity reduces, leading to price recovery, particularly benefiting the company's breeding-focused operations [5][19]. Financial Summary - Total revenue is projected to decline from RMB 3,225 million in 2023 to RMB 2,989 million in 2025, before recovering to RMB 3,514 million in 2026 and RMB 3,873 million in 2027 [4]. - Net profit attributable to the parent company is expected to drop significantly to RMB 196 million in 2025, but rebound to RMB 625 million in 2026 and RMB 818 million in 2027 [4]. - The company’s earnings per share (EPS) are forecasted to be RMB 0.18 in 2025, RMB 0.56 in 2026, and RMB 0.74 in 2027, reflecting a recovery trend [5][9].

Group 1 - Lichong Group expects a net profit of 830 million to 870 million yuan for 2025, representing a year-on-year growth of 17.38% to 23.04% [1] - Shandong Zhanggu anticipates a net profit of 72 million to 80 million yuan for 2025, with a year-on-year increase of 0.65% to 11.83% [2] - Yinglian Co. forecasts a net profit of 32 million to 42 million yuan for 2025, marking a turnaround from a loss of 39.67 million yuan in the previous year [3] Group 2 - Hangya Technology announces plans for shareholders to reduce their holdings by up to 2.76% of the company's shares [4] - Guizhou Tire plans to invest in a project in Morocco to produce 6 million semi-steel radial tires annually, with a total investment of 299 million USD [5] - Laisentongling's shareholder plans to reduce their stake by no more than 1% [6] Group 3 - ST Yifei's shareholder intends to reduce their holdings by up to 1.53% [7] - Hengyi Petrochemical has fully launched the second phase of its Brunei refining project, aiming for a production capacity of 12 million tons per year [8] - Zai Sheng Technology's controlling shareholder has terminated an agreement to transfer part of the company's shares [9] Group 4 - Sry New Materials proposes a cash dividend of 0.4 yuan per 10 shares for the first three quarters of 2025 [10] - Quanyin High-Tech announces that the offer period for China Seed Group's acquisition has expired, leading to a temporary suspension of its stock [11] - Zhonggang Luonai's shareholder plans to reduce their stake by up to 1% [12] Group 5 - Nanmo Bio expects to receive a government subsidy of 5.8 million yuan for its subsidiary [13] - Beite Technology has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [14] - Qianyuan Pharmaceutical's subsidiary has obtained drug registration certificates for a new medication [15] Group 6 - Boto Integrated plans to reduce its holdings by no more than 1% [16] - Wanze Co. intends to reduce its stake by up to 1.66% [17] - Tianci Materials will halt production for maintenance on its lithium hexafluorophosphate production line starting March 1, 2026 [18] Group 7 - Haopeng Technology plans to raise up to 800 million yuan through a private placement [20] - Yisheng Co. reports a 43.32% year-on-year increase in sales revenue for its white feather broiler chicks in December 2025 [21] - Jinyu Medical proposes a cash dividend of 8.8 yuan per 10 shares for the first three quarters of 2025 [22] Group 8 - Caesar Travel's subsidiary has won a management service project for the Qingdao International Cruise Port [23] - Kelun Pharmaceutical plans to repurchase shares worth 50 million to 100 million yuan [24] - Jiangling Motors reports a 10.56% year-on-year increase in cumulative sales for 2025 [25] Group 9 - Yilian Technology plans to issue convertible bonds to raise up to 1.2 billion yuan [26] - Shaanxi Guotou A intends to participate in a capital increase for Chang'an Bank, with an amount not exceeding 800 million yuan [27] - Oupokang Vision has obtained a production license for eye drops [28] Group 10 - Shanghai Electric plans to provide management services for overseas assets of China Electric International [30] - Yingfang Micro is planning a major asset restructuring, leading to a temporary suspension of its stock [31] - Victory Energy's stock will resume trading after completing a verification process [32] Group 11 - China Merchants Industry has signed a shipbuilding agreement with Dalian Shipbuilding [33] - Kunyu Group has appointed a new chairman following a board meeting [34] - Microchip Bio's clinical trial application for a new diabetes treatment has been accepted [35] Group 12 - Hanshuo Technology has signed a sales intention agreement for smart shopping carts with Woolworths in Australia [36] - Zhongmin Energy's three photovoltaic power station projects have been included in the Fujian Province development list [37] - Penghui Energy plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [38] Group 13 - Victory Energy reports that the acquirer has deposited a guarantee for the acquisition [39] - Fangsheng Pharmaceutical proposes a special dividend of 0.15 yuan per share for 2025 [40] - Nanning Department Store has received approximately 14.28 million yuan in government subsidies since January 2025 [41] Group 14 - Jushen Co. has signed a bauxite transfer agreement with a company in Guinea [42] - ST Huluwawa has received a drug registration certificate for a new inhalation solution [43] - Zhongzhi Co. will become the controlling shareholder following a share transfer agreement [44] Group 15 - Chuangli Group has signed a strategic cooperation framework agreement with Chuanjiu Construction [45]

专题：交易提示 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 【热点】 【业绩】 飞沃科技：公司近日完成收购新杉宇航60%股权；公司在商业航天领域的业务目前处于初始阶段。 胜通能源：停牌核查工作完成，股票复牌。 中材科技：2025年净利润同比预增73.79%—118.64%。 惠而浦：2025年归母净利润同比预增150%左右。 长江电力：2025年公司境内所属六座梯级电站总发电量同比增长3.82%。 桂冠电力：2025年累计完成发电量同比增长26.68%。 宇通客车：2025年累计销售量同比增长5.54%。 涛涛车业：2025年净利同比预增85.5%—97.1%。 南兴股份：预计2025年净利9000万元—1.2亿元，同比扭亏。 汉马科技：2025年累计货车（含非完整车辆）销量同比增长58.45%。 赤峰黄金：2025年净利润同比预增约70%到81%。 绿联科技：2025年净利同比预增41.26%—58.56%。 牧原股份：2025年12月商品猪销售收入96.67亿元，同比下降36.06%。 宁波港：2025年预计累计完成集装箱吞吐量同比增长11.2%。 华友钴业：2025年净利润 ...